HBC — Hofseth Biocare ASA Share News
0.000.00%
Last trade - 00:00- NOK548.79m
- NOK778.72m
- NOK256.34m
Brief: Hofseth Biocare Considers Unsecured Bond Issuance
Brief: Hofseth Biocare Signs Strategic Partnership With Symrise
Brief: Hofseth Biocare Q4 Adjusted EBITDA Loss NOK 26.1 Mln
Brief: Hofseth Biocare Q3 Revenue NOK 67.9 Million
Brief: Hofseth Biocare CFO Christel Elise Kanli Resigs
Brief: Hofseth Biocare Q2 Gross Oper Rev Up At NOK 80.4 Mln
Brief: Hofseth Biocare Transfers Eosinophil-Targeting Drug Candidate To Subsidiary
Brief: Reg-Hofseth Biocare Agrees China Distribution Partnership With Shanghai-Based Lithy
Brief: Hofseth Biocare Saw Solid Demand Growth In Ingredients Biz In Q1
Brief: Hofseth Biocare Q1 Revenue NOK 52 Million
Brief: Hofseth Biocare Chair Kristin Fjellby Grung Steps Down
Brief: Hofseth Cash And Cash Equivalents Rise By NOK 6.2 Mln In Q4
Brief: Hofseth Biocare Q4 Revenue at NOK 47.4 Million
Brief: Hofseth Biocare ASA Says Significant New Investment Of NOK 144 Mln From Hofseth International Into HBC
Brief: Hofseth Biocare Q3 Revenue NOK 49.9 Million
Brief: Hofseth Biocare Q2 EBIT at NOK 8.4 Million
Treatment Project To New U.S. Entity
Brief: Hofseth Biocare Q1 Revenue at NOK 44 Million
Brief: Hofseth Biocare Q3 Oper Loss Narrows To NOK 33.1 Million